Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis

Cell Growth and Differentiation

Volumn 8, Issue 3, 1997, Pages 293-299

  Houldsworth, Jane ^a   Reuter, Victor ^a   Bosl, George J ^a   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 12P; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE MAPPING; GERM CELL TUMOR; HELA CELL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CELL NUCLEUS; CHROMOSOMES, HUMAN, PAIR 12; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TESTICULAR NEOPLASMS; TESTIS; TUMOR CELLS, CULTURED;

EID: 0030905785     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ulbright, T. M. Germ cell neoplasms of the testis. Am. J. Surg. Pathol., 77: 1075-1091, 1993.
2. Chaganti, R. S. K., Murty, V. V. V. S., and Bosl, G. J. Molecular genetics of male germ cell tumors. In: N. J. Vogelzang, W. U. Shipley, P. T. Scardino, and D. S. Coffey (eds.), Comprehensive Textbook of Genitourinary Oncology, pp. 932-940. Baltimore, MD: Williams and Wilkins, 1996.
3. Voss, A. M., Oosterhuis, J. W., de Jong, B., Buist, J., and Koops, H. S. Cytogenetics of carcinoma in situ of the testis. Cancer Genet. Cytogenet., 46: 75-81, 1990.
4. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
5. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
6. 1 cyclin-dependent inhibitors. Genes Dev., 9: 1149-1163, 1995.
7. Won, K-A., Xiong, Y., Beach, D., and Gilman, M. Z. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 9910-9914, 1992.
8. Bartkova, J., Lukas, J., Strauss, M., and Bartek, J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10: 775-778, 1995.
9. 1 phase progression in specific cell types. Oncogene, 10: 2125-2134, 1995.
10. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin-dependent kinase CDK4. Genes Dev., 7: 331-342, 1993.
11. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J. Y., and Livingston, D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73: 487-497, 1993.
12. 1 progression. Oncogene, 9: 2663-2674, 1994.
13. 1 control in retinoblastoma gene-deficient cells, independent of CDK4 activity. Mol. Cell. Biol., 15: 2600-2611, 1995.
14. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. Retinoblastoma protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature (Lond.), 375: 503-506, 1995.
15. Steinman, R. A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D. A., and El-Houseini, M. E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene, 9: 3389-3396, 1994.
16. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lasser, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
17. Moasser, M. M., Reuter, V. E., and Dmitrovsky, E. Overexpression of the retinoic acid receptory directly induces terminal differentiation of human embryonal carcinoma cells. Oncogene, 10: 1537-1543, 1995.
18. Ravnick, S. E., Rhee, K., and Wolgemuth, D. J. Distinct patterns of expression of the D-type cyclins during testicular development in the mouse. Dev. Genet., 16: 171-178, 1995.
19. Lammie, G. A., Fantl, V., Smith R., Schuuring, E., Brookes, S., Michalides, R., Dickson, C., Arnold, A., and Peters, G. D11S128, a putative oncogene on chromosome 11q13 is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene, 6: 439-444, 1991.
20. Jiang, W., Kahan, S., Tomita, N., Zhang, Y., Lu, S., and Weinstein, B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res., 52: 2980-2983, 1992.
21. Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K. W., Musgrove, E. A., and Sutherland, R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8: 2127-2133, 1993.
22. Withers, D. A., Harvey, R. C., Faust, J. B., Melnyk, O., Carey, K, and Meeker, T. C. Characterization of a candidate bel-1 gene. Mol. Cell. Biol., 77: 4846-4853, 1991.
23. Seto, M., Yamamoto, K., Iida, S., Akao, Y., Utsumi, K. R., Kubonishi, I., Miyoshi, I., Ohtsuki, T., Yawata, Y., Namba, M., Motokura, T., Arnold, A., Takahashi, T., and Ueba, R. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene, 7: 1401-1406, 1992.
24. Motokura, T., Bloom, T., Kim, H. G., Juppner, H., Ruderman, J. V., Kronenberg, H. M., and Arnold, A. A novel cyclin encoded by a bcl-linked candidate oncogene. Nature (Lond.), 350: 512-515, 1991.
25. Leach, F. S., Elledge, S. J., Sherr, C. J., Willson, J. K. V., Markowitz, S., Kinzler, K. W., and Vogelstein, B. Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53: 1986-1989, 1993.
26. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J., 13: 3321-3328, 1994.
27. Dib, A., Adelaide, J., Courjal, F., Courseaux, A., Jacquemier, J., Gaudray, P., Theillet, C., Pebusque, M-J., and Birnbaum, D. Co-amplification in human breast tumors and physical linkage at chromosomal band 12p13. of CCND2 and FGF6 genes. Int. J. Oncol., 5: 1375-1378, 1994.
28. Hanna, Z., Jankowski, M., Tremblay, P., Jiang, X., Milatovich, A., Francke, U., and Jolicoeur, P. The vin-1 gene, identified by proviral insertional mutagenesis, is the cyclin D2. Oncogene, 8: 1661-1666, 1993.
29. Murty, V. V. V. S., Houldsworth, J., Baldwin, S., Reuter, V. E., Hunziker, W., Besmer, P., Bosl, G. J., and Chaganti, R. S. K. Allelic deletions in the long arm of chromosome 12 identifies sites of candidate tumor suppressor genes in male germ cell tumors. Proc. Natl. Acad. Sci. USA, 89: 11006-11010, 1992.
30. Murty, V. V. V. S., Li, R-G., Houldsworth, J., Bronson, D. L., Reuter, V. E., Bosl, G. J., and Chaganti, R. S. K. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors. Oncogene, 9: 3227-3231, 1994.
31. Andrews, P. W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol., 103: 285-293, 1984.
32. Pera, M. F., Cooper, S., Mills, J., and Parrington, J. M. Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation, 42: 10-23, 1989.
33. 1/S transition by cyclins D2 and D3 in hematopoetic cells. Proc. Natl. Acad. Sci. USA, 90: 9571-9575, 1993.
34. Roach, S., Schmid, W., and Pera, M. F. Hepatocyte transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3α in models of early endodermal cell differentiation. Exp. Cell Res., 215: 189-198, 1994.
35. Andrews, P. W., Nudelman, E., Hakomori, S-I., and Fenderson, B. A. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BudR). Differentiation, 43: 131-138, 1990.
36. Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., and Weinberg, R. A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82: 621-630, 1996.
37. Rodriguez, E., Houldsworth, J., Reuter, V. E., Meltzer, P., Zhang, J., Trent, J. M., Bosl, G. J., and Chaganti, R. S. K. Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosomes & Cancer, 8: 230-236, 1993.
38. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Current Protocols in Molecular Biology, Vols. 1-3. John Wiley and Sons, 1987-1995.
39. INK4/MTS1 tumor suppressor gene product. EMBO J., 74: 503-511, 1995.
40. Houldsworth, J., Mathew, S., Rao, P. H., Dyomina, K., Louie, D. C., Parsa, N., Offit, K., and Chaganti, R. S. K. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood, 87: 25-29, 1996.